| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1996;94:1216-1225.)
© 1996 American Heart Association, Inc.
Articles |
the Divisions of Cardiology (K.D.O'B.) and Metabolism, Endocrinology and Nutrition (J.E.H., S.W., A.C.), Department of Medicine; Department of Pathology (C.E.A.), School of Medicine; and Department of Epidemiology, School of Public Health and Community Medicine (J.E.H.), University of Washington, Seattle.
Correspondence to Kevin D. O'Brien, MD, Division of Cardiology, Box 356422, University of Washington, 1959 NE Pacific St, Seattle, WA 98195-6422. E-mail cardiac@u.washington.edu.
Background Previous small studies have demonstrated positive immunohistochemical staining in rabbit and human atherosclerotic plaques by antibodies that recognize oxidized low-density lipoprotein (OxLDL), but none have examined a large number of human coronary arteries or evaluated whether epitopes recognized by these antibodies might be present on plaque proteins other than OxLDL.
Methods and Results Immunohistochemistry was performed on atherosclerotic (n=87) and nonatherosclerotic (n=51) coronary arterial segments from 20 patients by use of monoclonal antibodies that recognize epitopes on macrophages, smooth muscle cells, apolipoprotein (apo) B, and OxLDL. Staining with the OxLDL antibody (Ox5) was much more prevalent in atherosclerotic than in control segments. Extracellular Ox5 staining colocalized with apo B, but cell-associated Ox5 staining occurred in the absence of cell-associated apo B staining, which suggests that cell-associated epitopes for Ox5 were on proteins other than LDL. Epitopes for Ox5 formed in vitro on two readily available nonapo B proteins, human serum albumin and apo A-I, when these proteins were incubated under conditions of oxidant stress with polyunsaturated but not monounsaturated fatty acids; furthermore, an antioxidant inhibited Ox5 epitope formation. Thus, epitopes for Ox5 can form on proteins other than apo B. Also, phorbol estertreated macrophages cultured in apo Bfree medium developed epitopes for Ox5.
Conclusions These findings are consistent with the hypothesis that atherosclerosis is associated with oxidative modification of proteins in addition to LDL, particularly cell-associated proteins, and that the antiatherosclerotic effects of antioxidants seen in some studies may not be solely due to prevention of LDL oxidation.
Key Words: apolipoproteins macrophages fatty acids immunohistochemistry antioxidants
This article has been cited by other articles:
![]() |
K. Subramaniam and J.-P. Yared Management of Pulmonary Hypertension in the Operating Room Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2007; 11(2): 119 - 136. [Abstract] [PDF] |
||||
![]() |
S. J. Nicholls and S. L. Hazen Myeloperoxidase and Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1102 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kamido, H. Eguchi, H. Ikeda, T. Imaizumi, K. Yamana, K. Hartvigsen, A. Ravandi, and A. Kuksis Core aldehydes of alkyl glycerophosphocholines in atheroma induce platelet aggregation and inhibit endothelium-dependent arterial relaxation J. Lipid Res., January 1, 2002; 43(1): 158 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Chang, S. Potter-Perigo, T. N. Wight, and A. Chait Oxidized LDL bind to nonproteoglycan components of smooth muscle extracellular matrices J. Lipid Res., May 1, 2001; 42(5): 824 - 833. [Abstract] [Full Text] |
||||
![]() |
W.S. Weintraub and D.G. Harrison C-reactive protein, inflammation and atherosclerosis: do we really understand it yet? Eur. Heart J., June 2, 2000; 21(12): 958 - 960. [PDF] |
||||
![]() |
K. L. Olin, S. Potter-Perigo, P. H. R. Barrett, T. N. Wight, and A. Chait Lipoprotein Lipase Enhances the Binding of Native and Oxidized Low Density Lipoproteins to Versican and Biglycan Synthesized by Cultured Arterial Smooth Muscle Cells J. Biol. Chem., December 3, 1999; 274(49): 34629 - 34636. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. O'Brien, C. Pineda, W. S. Chiu, R. Bowen, and M. A. Deeg Glycosylphosphatidylinositol-Specific Phospholipase D Is Expressed by Macrophages in Human Atherosclerosis and Colocalizes With Oxidation Epitopes Circulation, June 8, 1999; 99(22): 2876 - 2882. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Caligiuri, G. Liuzzo, L. M. Biasucci, and A. Maseri Immune system activation follows inflammation in unstable angina: pathogenetic implications J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1295 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. V. Bobryshev, R. S.A. Lord, T. Watanabe, and T. Ikezawa The cell adhesion molecule E-cadherin is widely expressed in human atherosclerotic lesions Cardiovasc Res, October 1, 1998; 40(1): 191 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Crawford, E. A. Kirk, M. E. Rosenfeld, R. C. LeBoeuf, and A. Chait Dietary Antioxidants Inhibit Development of Fatty Streak Lesions in the LDL Receptor–Deficient Mouse Arterioscler. Thromb. Vasc. Biol., September 1, 1998; 18(9): 1506 - 1513. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Stengel, M. Antonucci, W. Gaoua, C. Dachet, P. Lesnik, D. Hourton, E. Ninio, M. J. Chapman, and S. Griglio Inhibition of LPL Expression in Human Monocyte–Derived Macrophages Is Dependent on LDL Oxidation State : A Key Role for Lysophosphatidylcholine Arterioscler. Thromb. Vasc. Biol., July 1, 1998; 18(7): 1172 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Calara, P. Dimayuga, A. Niemann, J. Thyberg, U. Diczfalusy, J. L. Witztum, W. Palinski, P. K. Shah, B. Cercek, J. Nilsson, et al. An Animal Model to Study Local Oxidation of LDL and Its Biological Effects in the Arterial Wall Arterioscler. Thromb. Vasc. Biol., June 1, 1998; 18(6): 884 - 893. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |